Top compounds associated with response to RGL2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.048 0.2
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.042 0.2
mRNA Erlotinib gCSI pan-cancer AAC -0.075 0.2
mRNA avicin D CTRPv2 pan-cancer AAC 0.084 0.2
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.046 0.2
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.057 0.2
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.045 0.2
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.095 0.2
mRNA PI-103 CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV